Minimal bleeding risks observed with Factor Xa inhibitor management
A multicenter cohort study involving 1,902 patients with atrial fibrillation found that discontinuing Factor Xa inhibitors before low-risk procedures results in minimal complications. Following the Perioperative Factor Xa Inhibitor Discontinuation protocol, rates of major bleeding were just 0.1%, and no thromboembolic events occurred within 30 days post-procedure. These findings support a standardized approach for managing oral anticoagulant therapy in patients undergoing procedures where bleeding risk is low.
Closing a midline laparotomy with small, closely spaced fascial bites prevents more incisional hernias than the traditional large-bite technique, and the benefit lasts beyond two years.
Over five decades, surgery went from the most disruptive research field to the only one where papers, on average, reinforce existing ideas rather than redirect the field.
Members of the Society of American Gastrointestinal and Endoscopic Surgeons want a say in how surgery will work beyond Earth, and robotics tops their list.
